Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Toshiharu Ninomiya Last modified date:2022.04.08

Professor / Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University / Department of Basic Medicine / Faculty of Medical Sciences


Papers
1. Honda T, Ishida Y, Oda M, Noguchi K, Chen S, Sakata S, Oishi E, Furuta Y, Yoshida D, Hirakawa Y, Hata J, Kitazono T, Ninomiya T, Changes in body weight and concurrent changes in cardiovascular risk profiles in community residents in Japan: the Hisayama Study., J Atheroscler Thromb , 29, 252-267, 29: 252-267, 2022, 2022.02.
2. Yagita K, Honda H, Ohara T, Hamasaki H, Koyama S, Noguchi H, Mihara A, Nakazawa T, Hata J, Ninomiya T, Iwaki T, A Comparative Study of Site-Specific Distribution of Aging-Related tau astrogliopathy and its risk factors between alzheimer disease and cognitive healthy brains: the Hisayama Study., J Neuropathol Exp Neurol , 81, 106-116, 81: 106-116, 2022, 2022.01.
3. Hamasaki H, Shijo M, Nakamura A, Honda H, Yamada Y, Oda Y, Ohara T, Ninomiya T, Iwaki T, Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: the Hisayama Study., Brain Pathol , 32, e13014, 32: e13014, 2022, 2022.01.
4. Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, Fukagawa M, Matsushita K, Praditpornsilpa K, Hooi LS, Iseki K, Lin MY, Stirnadel-Farrant HA, Jha V, Jun M, Prevalence of chronic kidney disease in Asia: a systematic review and analysis., BMJ Glob Health , 7, e007525, 7: e007525, 2022, 2022.01.
5. Sumimoto Y, Yanagita M, Miyamatsu N, Okuda N, Nishi N, Nakamura Y, Nakamura K, Miyagawa N, Miyachi M, Kadota A, Ohkubo T, Okamura T, Ueshima H, Okayama A, Miura K; for NIPPON DATA2010 Research Group( Kiyohara Y, Ninomiya T), Association between socioeconomic status and physical inactivity in a general Japanese population: NIPPON DATA2010., PLoS One , 16, e0254706, 16: e0254706, 2021, 2020.07.
6. Iso H, Cui R, Takamoto I, Kiyama M, Saito I, Okamura T, Miyamoto Y, Higashiyama A, Kiyohara Y, Ninomiya T, Yamada M, Nakagawa H, Sakurai M, Shimabukuro M, Higa M, Shimamoto K, Saito S, Daimon M, Kayama T, Noda M, Ito S, Yokote K, Ito C, Nakao K, Yamauchi , Risk Classification for Metabolic Syndrome and the Incidence of cardiovascular disease in Japan with low prevalence of obesity: a pooled analysis of 10 prospective cohort studies., J Am Heart Assoc , 10, e020760, 10: e020760, 2021, 2021.12.
7. Imai Y, Mizuno Tanaka S, Satoh M, Hirata T, Murakami Y, Miura K, Waki T, Hirata A, Sairenchi T, Irie F, Sata M, Ninomiya T, Ohkubo T, Ishikawa S, Miyamoto Y, Ohnishi H, Saitoh S, Tamakoshi A, Yamada M, Kiyama M, Iso H, Sakata K, Nakagawa H, Okayama A, Ues, Prediction of lifetime risk of cardiovascular disease deaths stratified by sex in the Japanese population., J Am Heart Assoc 10: e021753, 2021, 10, e021753, J Am Heart Assoc 10: e021753, 2021, 2021.12.
8. Sasaki T, Nakagawa K, Hata J, Hirakawa Y, Shibata M, Nakano T, Tsuboi N, Oda Y, Kitazono T, Yokoo T, Ninomiya T, Pathologic diabetic nephropathy in autopsied diabetic cases with normoalbuminuria from a Japanese community-based study., Kidney Int Rep , 6, 3035-3044, 6: 3035-3044, 2021, 2021.09.
9. Tateishi Y, Yamada Y, Katsuki M, Nagata T, Yamamoto H, Kohashi K, Koga Y, Hashisako M, Kiyozawa D, Mori T, Kuboyama Y, Kakinokizono A, Miyazaki Y, Yamaguchi A, Tsutsui H, Ninomiya T, Naiki H, Oda Y, Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution., Pathol Res Pract , 227, 153635, 227: 153635, 2021, 2021.11.
10. Ganesh Chauhan, et al., Ninomiya T, Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. , Neurology , 92, e486-e503, 92: e486-e503, 2019, 2019.01.
11. Oshima M, Toyama T, Hara A, Shimizu M, Kitajima S, Iwata Y, Sakai N, Furuichi K, Haneda M, Babazono T, Yokoyama H, Iseki K, Araki SI, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Makino H, Wada T, Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes., BMJ Open Diabetes Res Care, 9, 9: e002311, 2021, 2021.06.
12. Nakamura K, Yoshida D, Honda T, Hata J, Shibata M, Hirakawa Y, Furuta Y, Kishimoto H, Ohara T, Chen S, Kitazono T, Nakashima Y, Ninomiya T, Midlife and late-life diabetes and sarcopenia in a general older Japanese population: the Hisayama Study., J Diabetes Investig, 12, 1899-1907, 12: 1899-1907, 2021, 2021.10.
13. NCD Risk Factor Collaboration (NCD-RisC)( Ninomiya T, Hata J), Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants., Lancet , 398, 957-980, 398: 957-980, 2021, 2021.09.
14. Sasaki T, Izumaru K, Hata J, Sakata S, Oishi E, Nagata T, Tsuboi N, Oda Y, Kitazono T, Yokoo T, Ninomiya T, Serum NT-proBNP levels and histopathological myocardial fibrosis in autopsied cases from a Japanese community: the Hisayama Study., J Cardiol , 78, 237-243, 78: 237-243, 2021, 2021.09.
15. Oishi E, Hata J, Honda T, Sakata S, Chen S, Hirakawa Y, Yoshida D, Shibata M, Ohara T, Furuta Y, Kitazono T, Ninomiya T, Development of a risk prediction model for incident hypertension in Japanese individuals: the Hisayama Study., Hypertens Res , 44, 1221-1229, 44: 1221-1229, 2021, 2021.09.
16. n-3 fatty acid biomarkers and incident type 2 diabetes: an individual participant-level pooling project of 20 prospective cohort studies., Qian F, Ardisson Korat AV, Imamura F, Marklund M, Tintle N, Virtanen JK, Zhou X, Bassett JK, Lai H, Hirakawa Y, Chien KL, Wood AC, Lankinen M, Murphy RA, Samieri C, Pertiwi K, de Mello VD, Guan W, Forouhi NG, Wareham N, Hu ICFB, Riserus U, Lind L, Harris , Diabetes Care , 44, 1133-1142, 44: 1133-1142, 2021.05.
17. Harris WS, Tintle NL, Imamura F, Qian F, Korat AVA, Marklund M, Djoussé L, Bassett JK, Carmichael PH, Chen YY, Hirakawa Y, Küpers LK, Laguzzi F, Lankinen M, Murphy RA, Samieri C, Senn MK, Shi P, Virtanen JK, Brouwer IA, Chien KL, Eiriksdottir G, Forouhi N, Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies., Nat Commun , 12, 2329, 12: 2329, , 2021.04.
18. Sasaki M, Miyake M, Fujiwara K, Nanba H, Akiyama M, Yanagi Y, Harada S, Tabara Y, Yasuda M, Yamashita H, Kayama T, Tsubota K, Matsuda F, Hashimoto S, Ueda E, Ninomiya T, Takebayashi T, Tsujikawa A, Sonoda KH, Kawasaki R, Cohort Profile: The Ganka-Ekigaku Network (GEN), a network of Japanese ophthalmological epidemiology studies., Ophthalmic Epidemiol , 237-243, 237-243, 2021, 2021.06.
19. Sasaki T, Oishi E, Nagata T, Sakata S, Chen S, Furuta Y, Honda T, Yoshida D, Hata J, Tsuboi N, Kitazono T, Yokoo T, Ninomiya T, N-terminal pro-B-type natriuretic peptide and incident CKD., Kidney Int Rep , 6, 976-985, Kidney Int Rep 6: 976-985, 2021, 2021.06.
20. Ohara T, Yoshida D, Hata J, Shibata M, Honda T, Furuta Y, Hirabayashi N, Kitazono T, Nakao T, Ninomiya T, Current status of the certification of long-term care insurance among individuals with dementia in a Japanese community: the Hisayama Study., Psychiatry Clin Neurosci , 75, 182-184, 75: 182-184, 2021, 2021.05.
21. Kimura Y, Yoshida D, Hirakawa Y, Hata J, Honda T, Shibata M, Sakata S, Uchida K, Kitazono T, Ninomiya T, Dietary fiber intake and risk of type 2 diabetes in a general Japanese population: the Hisayama Study., J Diabetes Investig , 12, 527-536, 12: 527-536, 2021, 2021.04.
22. Yamasaki K, Hata J, Ide T, Nagata T, Sakata S, Yoshida D, Honda T, Hirakawa Y, Nakano T, Kitazono T, Tsutsui H, Ninomiya T , Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study., Environ Health Prev Med , 26, 47, Environ Health Prev Med 26: 47, 2021, 2021.04.
23. Chen S, Honda T, Hata J, Sakata S, Furuta Y, Yoshida D, Shibata M, Ohara T, Hirakawa Y, Oishi E, Kitazono T, Ninomiya T, High serum folate concentrations are associated with decreased risk of mortality among Japanese adults., J Nutr , 151, 657-665, 151: 657-665, 2021, 2021.03.
24. Igarashi Y, Nochioka K, Sakata Y, Tamai T, Ohkouchi S, Irokawa T, Ogawa H, Hayashi H, Fujihashi T, Yamanaka S, Shiroto T, Miyata S, Hata J, Yamada S, Ninomiya T, Yasuda S, Kurosawa H, Shimokawa H, Risk prediction for new-onset atrial fibrillation using the Minnesota code electrocardiography classification system., Int J Cardiol Heart Vasc , 34, 34: 100762, 2021, 2021.03.
25. Yoshimura M, Honda H, Sasagasako N, Mori S, Hamasaki H, Suzuki SO, Ishii T, Ninomiya T, Kira JI, Iwaki T, PCBP2 is downregulated in degenerating neurons and rarely observed in TDP-43-Positive inclusions in sporadic amyotrophic lateral sclerosis., J Neuropathol Exp Neurol , 80, 220-228, 80: 220-228, 2021, 2021.02.
26. Nakamura K, Yoshida D, Honda T, Hata J, Shibata M, Hirakawa Y, Furuta Y, Kishimoto H, Ohara T, Kitazono T, Nakashima Y, Ninomiya T, Prevalence and mortality of sarcopenia in a community-dwelling older Japanese population: the Hisayama Study., J Epidemiol , 31, 320-327, 31: 320-327, 2021, 2021.05.
27. Shikata K, Haneda M, Ninomiya T, Koya D, Suzuki Y, Suzuki D, Ishida H, Akai H, Tomino Y, Uzu T, Nishimura M, Maeda S, Ogawa D, Miyamoto S, Makino H; Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan) collaborative group, Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)., J Diabetes Investig , 12, 207-216, 12: 207-216, 2021, 2021.02.
28. Higashioka M, Sakata S, Honda T, Hata J, Shibata M, Yoshida D, Goto K, Kitazono T, Osawa H, Ninomiya T, The association of small dense low-density lipoprotein cholesterol and coronary heart disease in subjects at high cardiovascular risk., J Atheroscler Thromb , 28, 79-89, 28: 79-89, 2021, 2021.01.
29. Sasaki M, Miyake M, Fujiwara K, Nanba H, Akiyama M, Yanagi Y, Harada S, Tabara Y, Yasuda M, Yamashita H, Kayama T, Tsubota K, Matsuda F, Hashimoto S, Ueda E, Ninomiya T, Takebayashi T, Tsujikawa A, Sonoda KH, Kawasaki R, Cohort profile: The Ganka-Ekigaku Network (GEN), a network of Japanese ophthalmological epidemiology studies., Ophthalmic Epidemiol , 13, 1-7, 13: 1-7, 2020, 2020.08.
30. Asayama K, Tabara Y, Oishi E, Sakata S, Hisamatsu T, Godai K, Kabayama M, Tatsumi Y, Hata J, Kikuya M, Kamide K, Miura K, Ninomiya T, Ohkubo T, Recent status of self-measured home blood pressure in the Japanese general population: a modern database on self-measured home blood pressure (MDAS)., Hypertens Res, 43, 1403, 1412, 43: 1403-1412, 2020, 2020.12.
31. Imai Y, Hirata T, Saitoh S, Ninomiya T, Miyamoto Y, Ohnishi H, Murakami Y, Iso H, Tanaka S, Miura K, Tamakoshi A, Yamada M, Kiyama M, Ueshima H, Ishikawa S, Okamura T; Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group, Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study., Hypertens Res , 43, 1437, 1444, 43: 1437-1444, 2020, 2020.11.
32. Tomiyama H, Vlachopoulos C, Xaplanteris P, Nakano H, Shiina K, Ishizu T, Kohro T, Higashi Y, Takase B, Suzuki T, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Tanaka A, Maemura K, Ohya Y, Furukawa T, Ito H, Ohkuma T, Ninomiya T, Chikamori T, Yamashina A, Ueda SI, Usefulness of the SAGE score to predict elevated values of brachial-ankle pulse wave velocity in Japanese subjects with hypertension., Hypertens Res, 43, 1284-1292, 43: 1284-1292, 2020, 2020.11.
33. NCD Risk Factor Collaboration (NCD-RisC)(Ninomiya T, Hata J), Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants., Lancet, 396, 1511-1524, 396: 1511-1524, 2020, 2020.11.
34. Ninomiya T, Nakaji S, Maeda T, Yamada M, Mimura M, Nakashima K, Mori T, Takebayashi M, Ohara T, Hata J, Kokubo Y, Uchida K, Taki Y, Kumagai S, Yonemoto K, Yoshida H, Muto K, Momozawa Y, Akiyama M, Kubo M, Ikeda M, Kanba S, Kiyohara Y; JPSFC-AD Study Group, Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)., Environ Health Prev Med , 25, 64-76, 25: 64-76, 2020, 2020.10.
35. Nagata T, Hata J, Sakata S, Oishi E, Honda T, Furuta Y, Ohara T, Yoshida D, Hirakawa Y, Shibata M, Ide T, Kitazono T, Tsutsui H, Ninomiya T, Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: the Hisayama Study., Int J Cardiol , 320, 90-96, Int J Cardiol 320: 90-96, 2020, 2020.12.
36. Ishida Y, Yoshida D, Honda T, Hirakawa Y, Shibata M, Sakata S, Furuta Y, Oishi E, Hata J, Kitazozno T, Ninomiya T, Influence of the accumulation of unhealthy eating habits on obesity in a general Japanese population: the Hisayama Study., Nutrients , 12, Nutrients 12: E3160, 2020, 2020.10.
37. Sasaki T, Tsuboi N, Marumoto H, Okabayashi Y, Haruhara K, Kanzaki G, Koike K, Ogura M, Ninomiya T, Yokoo T, Nephron number and time to remission in steroid-sensitive minimal change disease. , Kidney Med , 2, 559-568, Kidney Med 2: 559-568, 2020, 2020.08.
38. McGrath ER, Himali JJ, Levy D, Conner SC, DeCarli C, Pase MP, Ninomiya T, Ohara T, Courchesne P, Satizabal CL, Vasan RS, Beiser AS, Seshadri S, Growth differentiation factor 15 and NT-proBNP as blood-based markers of vascular brain injury and dementia. , J Am Heart Assoc , 9, J Am Heart Assoc 9: e014659, 2020, 2020.10.
39. Yoshida D, Ohara T, Hata J, Shibata M, Hirakawa Y, Honda T, Furuta Y, Oishi E, Sakata S, Kanba S, Kitazono T, Ninomiya T, Lifetime cumulative incidence of dementia in a community-dwelling elderly population in Japan. , Neurology, 95, Neurology 95: e508-e518, 2020, 2020.08.
40. Shibata M, Ninomiya T, Anno K, Kawata H, Iwaki R, Sawamoto R, Kubo C, Kiyohara Y, Sudo N, Hosoi M, Parenting style during childhood is associated with the development of chronic pain and a patient's need for psychosomatic treatment in adulthood: A case-control study. , Medicine (Baltimore) , 99, Medicine (Baltimore) 99: e21230, 2020, 2020.08.
41. Higashioka M, Sakata S, Honda T, Hata J, Yoshida D, Hirakawa Y, Shibata M, Goto K, Kitazono T, Osawa H, Ninomiya T, Small dense low-density lipoprotein cholesterol and the risk of coronary heart disease in a Japanese community., J Atheroscler Thromb, 27, 669-682, J Atheroscler Thromb 27: 669-682, 2020, 2020.07.
42. NCD Risk Factor Collaboration (NCD-RisC)(Ninomiya T, Hata J), Repositioning of the global epicentre of non-optimal cholesterol., Nature , 582, 73-77, Nature 582: 73-77, 2020, 2020.06.
43. Oku S, Takeshita T, Futatsuki T, Kageyama S, Asakawa M, Mori Y, Miyamoto T, Hata J, Ninomiya T, Kashiwazaki H, Yamashita Y, Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation. , PLoS Pathog , 16, PLoS Pathog 16: e1008348, 2020, 2020.03.
44. Mihara A, Ohara T, Hata J, Honda T, Chen S, Sakata S, Oishi E, Hirakawa Y, Nakao T, Kitazono T, Ninomiya T, Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: the Hisayama Study., Atherosclerosis , 311, 52-59, Atherosclerosis 311: 52-59, 2020, 2020.08.
45. Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Ohno-Matsui K, Hata J, Ishibashi T, Ninomiya T, Sonoda KH, Five-year incidence of myopic maculopathy in a general Japanese population: the Hisayama Study. , JAMA Ophthalmol 3, 2020, 138, 887-893, JAMA Ophthalmol 138: 887-893, 2020, 2020.08.
46. Ohara T, Furuta Y, Hirabayashi N, Hata J, Hirakawa Y, Honda T, Yoshida D, Shibata M, Kitazono T, Ninomiya T, Elevated serum glycated albumin and glycated albumin : hemoglobin A(1c) ratio were associated with hippocampal atrophy in a general elderly population of Japanese: the Hisayama Study. , J Diabetes Investig , 11, 971-979, J Diabetes Investig 11: 971-979, 2020, 2020.07.
47. Hirakawa Y, Hata J, Yoshinari M, Higashioka M, Yoshida D, Shibata M, Honda T, Sakata S, Kato H, Teramoto T, Maki H, Nishimoto S, Kitazono T, Ninomiya T, 30-minute postload plasma glucose levels during an oral glucose tolerance test predict the risk of future type 2 diabetes: the Hisayama Study, BMJ Open Diabetes Res Care , 8, BMJ Open Diabetes Res Care 8: e001156, 2020, 2020.07.
48. Lee CM, Woodward M, Batty GD, Beiser AS, Bell S, Berr C, Bjertness E, Chalmers J, Clarke R, Dartigues JF, Davis-Plourde K, Debette S, Di Angelantonio E, Feart C, Frikke-Schmidt R, Gregson J, Haan MN, Hassing LB, Hayden KM, Hoevenaar-Blom MP, Kaprio J, Kivimaki M, Lappas G, Larson EB, LeBlanc ES, Lee A, Lui LY, Moll van Charante EP, Ninomiya T, Nordestgaard LT, Ohara T, Ohkuma T, Palviainen T, Peres K, Peters R, Qizilbash N, Richard E, Rosengren A, Seshadri S, Shipley M, Singh-Manoux A, Strand BH, van Gool WA, Vuoksimaa E, Yaffe K, Huxley RR, Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia., Obes Rev 21: e12989, 2020, 2020.04.
49. Sakata S, Hata J, Honda T, Hirakawa Y, Oishi E, Shibata M, Yoshida D, Goto K, Kitazono T, Ninomiya T, Serum uric acid levels and cardiovascular mortality in a general Japanese population: the Hisayama Study., Hypertens Res, 43, 560-568, Hypertens Res 43: 560-568, 2020, 2020.06.
50. Yamasaki K, Hata J, Furuta Y, Hirabayashi N, Ohara T, Yoshida D, Hirakawa Y, Nakano T, Kitazono T, Ninomiya T, Association of albuminuria with white matter hyperintensities volume on brain magnetic resonance imaging in elderly Japanese - the Hisayama Study., Circ J , 84, 935-942, Circ J 84: 935-942, 2020, 2020.05.
51. Hachiya T, Hata J, Hirakawa Y, Yoshida D, Furuta Y, Kitazono T, Shimizu A, Ninomiya T, Genome-wide polygenic score and the risk of ischemic stroke in a prospective cohort: the Hisayama Study., Stroke 51: 759-765, 51, 759-765, Stroke 51: 759-765, 2020, 2020.03.
52. Higashioka M, Hirakawa Y, Kawamura R, Honda T, Hata J, Yoshida D, Takata Y, Kitazono T, Osawa H, Ninomiya T, Ratios of serum eicosapentaenoic acid to arachidonic acid and docosahexaenoic acid to arachidonic acid were inversely associated with serum resistin levels: the Hisayama Study., J Diabetes Investig , 11, 482-489, J Diabetes Investig 11: 482-489, 2020, 2020.03.
53. Tully PJ, Yano Y, Launer LJ, Kario K, Nagai M, Mooijaart SP, Claassen JAHR, Lattanzi S, Vincent AD, Tzourio C; Variability in Blood Pressure and Brain Health Consortium †; Variability in Blood Pressure and Brain Health Consortium (Ninomiya T, Ohara T, Oishi E), Association between blood pressure variability and cerebral small-vessel disease: a systematic review and meta-analysis., J Am Heart Assoc, 9, e013841, J Am Heart Assoc 9: e013841, 2020, 2020.01.
54. Yang Y, Hozawa A, Kogure M, Narita A, Hirata T, Nakamura T, Tsuchiya N, Nakaya N, Ninomiya T, Okuda N, Kadota A, Ohkubo T, Okamura T, Ueshima H, Okayama A, Miura K, Dietary inflammatory index positively associated with high-sensitivity C-reactive protein level in Japanese from NIPPON DATA2010., J Epidemiol, 30, 98-107, J Epidemiol 30: 98-107, 2020, 2020.02.
55. Hatabe Y, Shibata M, Ohara T, Oishi E, Yoshida D, Honda T, Hata J, Kanba S, Kitazono T, Ninomiya T, Decline in handgrip strength from midlife to late-life is associated with dementia in a Japanese community: the Hisayama Study., J Epidemiol , 30, 15-23, J Epidemiol 30: 15-23, 2020, 2020.01.
56. WHO CVD Risk Chart Working Group (Hisayama: Ninomiya T, Hata J, Hirakawa Y), World health organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions., Lancet Glob Health , 7, e1332-e1345, Lancet Glob Health 7: e1332-e1345, 2019, 2019.10.
57. Tomiyama H, Ohkuma T, Ninomiya T, Nakano H, Matsumoto C, Avolio A, Kohro T, Higashi Y, Maruhashi T, Takase B, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y,, Brachial-ankle pulse wave velocity versus its stiffness index β-transformed value as risk marker for cardiovascular disease., J Am Heart Assoc, 8, e013004, J Am Heart Assoc 8: e013004, 2019, 2020.12.
58. Sasaki T, Tsuboi N, Okabayashi Y, Haruhara K, Kanzaki G, Koike K, Kobayashi A, Yamamoto I, Takahashi S, Ninomiya T, Shimizu A, Rule AD, Bertram JF, Yokoo T, Estimation of nephron number in living humans by combining unenhanced computed tomography with biopsy-based stereology., Sci Rep, 9, 14400, Sci Rep 9: 14400, 2019, 2019.10.
59. Jardine MJ, Li N, Ninomiya T, Feng X, Zhang J, Shi J, Zhang Y, Zhang R, Zhang J, Hao J, Perkovic V, Heerspink HL, Wu Y, Yan LL, Neal B, Dietary sodium reduction reduces albuminuria: a cluster randomized trial., J Ren Nutr , 29, 276-284, J Ren Nutr 29: 276-284, 2019, 2019.07.
60. Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, Suma S, Shibata Y, Shimazaki Y, Hata J, Ninomiya T, Nakanishi Y, Inoue H, Yamashita Y, Periodontitis is associated with chronic obstructive pulmonary disease., J Dent Res, 98, 534-540, J Dent Res 98: 534-540, 2019, 2019.05.
61. Fujiwara K, Yasuda M, Hata J, Yoshida D, Kishimoto H, Hashimoto S, Yoshitomi T, Ninomiya T, Sonoda KH, Long-term regular exercise and intraocular pressure: the Hisayama Study., Graefes Arch Clin Exp Ophthalmol , 257, 2461-2469, Graefes Arch Clin Exp Ophthalmol 257: 2461-2469, 2019, 2019.11.
62. Asada M, Oishi E, Sakata S, Hata J, Yoshida D, Honda T, Furuta Y, Shibata M, Suzuki K, Watanabe H, Murayama N, Kitazono T, Yamaura K, Ninomiya T, Serum lipopolysaccharide-binding protein levels and the incidence of cardiovascular disease in a general Japanese population: the Hisayama Study., J Am Heart Assoc , 8, e013628, J Am Heart Assoc 8: e013628, 2019, 2019.11.
63. Honda T, Ohara T, Shinohara M, Hata J, Toh R, Yoshida D, Shibata M, Ishida T, Hirakawa Y, Irino Y, Sakata S, Uchida K, Kitazono T, Kanba S, Hirata KI, Ninomiya T, Serum elaidic acid concentration and risk of dementia: the Hisayama Study., Neurology , 93, e2053-e2064, Neurology 93: e2053-e2064, 2019, 2019.11.
64. Marklund M, Wu JHY, Imamura F, Del Gobbo LC, Fretts A, de Goede J, Shi P, Tintle N, Wennberg M, Aslibekyan S, Chen TA, de Oliveira Otto MC, Hirakawa Y, Eriksen HH, Kröger J, Laguzzi F, Lankinen M, Murphy RA, Prem K, Samieri C, Virtanen J, Wood AC, Wong K,, Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality., Circulation, 139, 2422-2436, Circulation 139: 2422-2436, 2019, 2019.05.
65. Takeshita T, Matsuo K, Furuta M, Shibata Y, Fukami K, Shimazaki Y, Akifusa S, Han DH, Kim HD, Yokoyama T, Ninomiya T, Kiyohara Y, Yamashita Y., Distinct composition of the oral indigenous microbiota in South Korean and Japanese adults., Sci Rep, 4, 6990, Sci Rep 4: 6990, 2014, 2014.11.
66. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (Doi Y, Hata J, Kiyohara Y, Ninomiya T)., Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment., Lancet Diabetes Endocrinol, 2, 634-647, Lancet Diabetes Endocrinol 2: 634-647, 2014, 2014.08.
67. Emerging Risk Factors Collaboration (Kiyohara Y, Arima H, Ninomiya T, Hata J)., Glycated hemoglobin measurement and prediction of cardiovascular disease., JAMA, 311, 1225-1233, JAMA 311: 1225-1233, 2014, 2014.03.
68. Pennells L, Kaptoge S, White IR, Thompson SG, Wood AM; Emerging Risk Factors Collaboration (Kiyohara Y, Arima H, Doi Y, Ninomiya T)., Assessing risk prediction models using individual participant data from multiple studies., Am J Epidemiol, 179, 621-632, Am J Epidemiol 179: 621-632, 2014, 2014.03.
69. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects)(Hata J, Kiyohara Y, Ninomiya T), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G., Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants., Lancet, 383, 970-983, 383: 970-983, 2014, 2014.03.
70. Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki SI, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, The Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes., Clin Exp Nephrol , 18, 621-622, 18: 621-622, 2014, 2014.06.
71. Hokama M, Oka S, Leon J, Ninomiya T, Honda H, Sasaki K, Iwaki T, Ohara T, Sasaki T, Laferla FM, Kiyohara Y, Nakabeppu Y., Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama Study., Cereb Cortex, 24, 2476-2488, 24: 2476-2488, 2014, 2014.09.
72. Hirakawa Y, Arima H, Zoungas S, Ninomiya T, Cooper M, Hamet P, Mancia G, Poulter N, Harrap S, Woodward M, Chalmers J, Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE Trial., Diabetes Care, 37: 2359-2365, 2014, 2014.08.
73. Shigemizu D, Abe T, Morizono T, Johnson TA, Boroevich KA, Hirakawa Y, Ninomiya T, Kiyohara Y, Kubo M, Nakamura Y, Maeda S, Tsunoda T, The construction of risk prediction models using GWAS data and its application to a type 2 diabetes prospective cohort., PLoS One, 20, e92549, 20; 9: e92549, 2014, 2014.03.
74. Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y, Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression., Arterioscler Thromb Vasc Biol, 34, 790-800, 34: 790-800, 2014, 2014.02.
75. Kiyohara T, Kamouchi M, Kumai Y, Ninomiya T, Hata J, Yoshimura S, Ago T, Okada Y, Kitazono T; for the FSR investigators; Fukuoka Stroke Registry Investigators, ABCD3 and ABCD3-I Scores Are Superior to ABCD2 Score in the Prediction of Short- and Long-Term Risks of Stroke After Transient Ischemic Attack., Stroke, 45, 418-425, 45: 418-425, 2014, 2014.02.
76. Furuta M, Shimazaki Y, Takeshita T, Shibata Y, Akifusa S, Eshima N, Kiyohara Y, Ninomiya T, Hirakawa Y, Mukai N, Nagata M, Yamashita Y, Gender differences in the association between metabolic syndrome and periodontal disease: the Hisayama Study., J Clin Periodontol, 40, 743-752, 40: 743-752, 2013, 2013.08.
77. Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, Foote C, Rodgers A, Hong Z, Wang H, Strippoli GF, Perkovic V, Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis., CMAJ, 185, 949-957, 185: 949-957, 2013, 2013.08.
78. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group(Ninomiya T), The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008., Circulation, 127, 1493-1502, 127: 1493-1502, 2013, 2013.04.
79. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H,Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry(Ninomiya T); Japanese Society of Nephrology, Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010., Clin Exp Nephrol 17: 155-173, 2013, 17, 155-173, 17: 155-173, 2013, 2013.04.
80. Hirano A, Yamazaki K, Umeno J, Ashikawa K, Aoki M, Matsumoto T, Nakamura S, Ninomiya T, Matsui T, Hirai F, Kawaguchi T, Takazoe M, Tanaka H, Motoya S, Kiyohara Y, Kitazono T, Nakamura Y, Kamatani N, Kubo M, Association Study of 71 European Crohn's Disease Susceptibility Loci in a Japanese Population., Inflamm Bowel Dis 19: 526-533, 2013, 19, 526-533, 19: 526-533, 2013, 2013.03.
81. Hata J, Arima H, Zoungas S, Fulcher G, Pollock C, Adams M, Watson J, Joshi R, Kengne AP, Ninomiya T, Anderson C, Woodward M, Patel A, Mancia G, Poulter N, MacMahon S, Chalmers J, Neal B, ADVANCE Collaborative Group: Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial., PLoS One 8: e55807, 2013, 8, e55807, PLoS One 8: e55807, 2013, 2013.02.
82. Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, Idewaki Y, Ide H, Doi Y, Hirakawa Y, Mukai N, Ninomiya T, Uchida K, Nakamura U, Sasaki S, Kiyohara Y, Kitazono T, Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study., Diabetologia, 56, 70-77, Diabetologia 56:70-77 2013, 2013.01.
83. Doi Y, Ninomiya T, Hirakawa Y, Takahashi O, Mukai N, Hata J, Iwase M, Kitazono T, Oike Y, Kiyohara Y, Angiopoietin-Like Protein 2 and Risk of Type 2 Diabetes in a General Japanese Population: the Hisayama Study., Diabetes Care, 36, 98-100, 36: 98-100, 2013, 2013.01.
84. Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, Makino H, Watanabe T, Saito T, Kiyohara Y, Nishi S, Iida H, Morozumi K, Fukatsu A, Sasaki T, Tsuruya K, Kohda Y, Higuchi M, Kiyomoto H, Goto S, Hattori M, Hataya H, Kagami S, Yoshikawa N, Fukasawa Y, Ueda Y, Kitamura H, Shimizu A, Oka K, Nakagawa N, Ito T, Uchida S, Furuichi K, Nakaya I, Umemura S, Hiromura K, Yoshimura M, Hirawa N, Shigematsu T, Fukagawa M, Hiramatsu M, Terada Y, Uemura O, Kawata T, Matsunaga A, Kuroki A, Mori Y, Mitsuiki K, Yoshida H, Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology(Ninomiya T), and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan: Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR)., Clin Exp Nephrol, 16, 903-920, 16: 903-920, 2012, 2012.12.
85. Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M, Mancia G, Mogensen CE, Poulter N, Chalmers J, the ADVANCE Collaborative Group: Prediction of kidney-related outcomes in patients with type 2 diabetes., Am J Kidney Dis, 60, 770-778, 60: 770-778, 2012, 2012.11.
86. Emerging Risk Factors Collaboration(Ninomiya T), Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J, C-reactive protein, fibrinogen, and cardiovascular disease prediction., N Engl J Med, 367, 1310-1320, N Engl J Med 367: 1310-1320, 2012, 2012.10.
87. Emerging Risk Factors Collaboration(Ninomiya T), Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis., Int J Epidemiol, 41, 1419-1433, Int J Epidemiol 41: 1419-1433, 2012, 2012.07.
88. Asakuma T, Yasuda M, Ninomiya T, Noda Y, Arakawa S, Hashimoto S, Ohno-Matsui K, Kiyohara Y, Ishibashi T, Prevalence and risk factors for myopic retinopathy in a Japanese population: the Hisayama Study., Ophthalmology, 119, 1760-1765, Ophthalmology 119: 1760-1765, 2012, 2012.09.
89. Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, Wang H, Macmahon S, Turnbull F, Hillis G, Chalmers J, Perkovic V, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis., PLoS Med, 9, e1001293, PLoS Med 9 e1001293, 2012, 2012.08.
90. Masutani K, Shapiro R, Basu A, Tan H, Ninomiya T, Randhawa P, Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia., Transplantation, 94, 43-49, Transplantation 94: 43-49, 2012, 2012.07.
91. Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V, The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. , BMJ , 344, 3533, 344: e3533, 2012, 2012.06.
92. Hillis GS, Woodward M, Rodgers A, Chow CK, Li Q, Zoungas S, Patel A, Webster R, Batty GD, Ninomiya T, Mancia G, Poulter NR, Chalmers J, Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus., Diabetologia, 55, 1283-1290, 55: 1283-1290, 2012, 2012.10.
93. Gotoh S, Doi Y, Hata J, Ninomiya T, Mukai N, Fukuhara M, Kamouchi M, Kitazono T, Kiyohara Y, Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama Study., J Atheroscler Thromb, 19, 977-985, 19: 977-985, 2012, 2012.07.
94. Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V, Antioxidants for chronic kidney disease., Cochrane Database Syst Rev, 10, 10: CD008176, 2012, 2012.10.
95. Miyazaki M, Doi Y, Ikeda F, Ninomiya T, Hata J, Uchida K, Shirota T, Matsumoto T, Iida M, Kiyohara Y, Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study., Gastric Cancer, 15, 162-169, Gastric Cancer 15: 162-169, 2012, 2011.04.
96. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Nagata M, Kawamura T, Honda M, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis and Working Group for Renal Biopsy Database, Japanese Society of Nephrology, Tokyo, Japan (Ninomiya T)., Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan., Clin Exp Nephrol, 15, 493-503, Clin Exp Nephrol. 15: 493-503,, 2011.08.
97. Matsuzaki T, Sasaki K, Hata J, Hirakawa Y, Fujimi K, Ninomiya T, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T, Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study., Neurology, 77, 1068-1075, 77: 1068-1075, 2011, 2011.09.
98. Arakawa S, Yasuda M, Nagata M, Ninomiya T, Hirakawa Y, Doi Y, Kiyohara Y, Ishibashi T, Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama Study., Invest Ophthalmol Vis Sci, 52, 5905-5909, Invest Ophthalmol Vis Sci 52: 5905-5909, 2011, 2011.07.
99. Yasuda M, Kiyohara Y, Wang JJ, Arakawa S, Yonemoto K, Doi Y, Ninomiya T, Ishibashi T, High serum bilirubin levels and diabetic retinopathy: the Hisayama Study., Ophthalmology, 118, 1423-1428, 118: 1423-1428, 2011, 2011.06.
100. Chronic Kidney Disease Prognosis Consortium(Ninomiya T), Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, Landray MJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B, Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T, Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts., Kidney Int, 79, 1331-1340, 79: 1331-1340, 2011, 2011.12.
101. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure) (Ninomiya T), National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants., Lancet, 377, 568-577, 377: 568-577, 2011, 2011.02.
102. Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, Sarwar N, Kizer JR, Lawlor DA, Nordestgaard BG, Ridker P, Salomaa V, Stevens J, Woodward M, Sattar N, Collins R, Thompson SG, Whitlock G, Danesh J; the Emerging Risk Factors Collaboration(Ninomiya T), Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies., Lancet, 377, 1085-1095, 377: 1085-1095. 2011, 2011.03.
103. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J; the Emerging Risk Factors Collaboration(Ninomiya T), Diabetes mellitus, fasting glucose, and risk of cause-specific death., N Engl J Med, 364, 829-841, 829-841, 2011, 2011.03.
104. Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, Oda Y, Kitazono T, Ninomiya T, Reduced Estimated GFR and Cardiac Remodeling: A Population-Based Autopsy Study., Am J Kidney Dis. , 74, 3, 373-381, 2019 Sep;74(3):373-381, 2019.11.
105. Hashimoto S, Yasuda M, Fujiwara K, Ueda E, Hata J, Hirakawa Y, Ninomiya T, Sonoda KH, Association between Axial Length and Myopic Maculopathy: The Hisayama Study., Ophthalmol Retina , 863-873, 3: 867-873, 2019, 2019.10.
106. Hata J, Ohara T, Katakura Y, Shimizu K, Yamashita S, Yoshida D, Honda T, Hirakawa Y, Shibata M, Sakata S, Kitazono T, Kuhara S, Ninomiya T, Association Between Serum β-Alanine and Risk of Dementia., Am J Epidemiol , 1637-1645, 188: 1637-1645, 2019, 2019.09.
107. Fujiwara K, Yasuda M, Hata J, Hirakawa Y, Hashimoto S, Ueda E, Iwase A, Araie M, Yoshitomi T, Ninomiya T, Sonoda KH, Glucose Tolerance Levels and Circumpapillary Retinal Nerve Fiber Layer Thickness in a General Japanese Population: The Hisayama Study., Am J Ophthalmol , 140-146, 205: 140-146, 2019, 2019.09.
108. Honda T, Kishimoto H, Mukai N, Hata J, Yoshida D, Hirakawa Y, Shibata M, Ohara T, Kumagai S, Ninomiya T, Objectively measured sedentary time and diabetes mellitus in a general Japanese population: The Hisayama Study., J Diabetes Investig , 10: 809-816, 2019, 2019.08.
109. Inaishi J, Hirakawa Y, Horikoshi M, Akiyama M, Higashioka M, Yoshinari M, Hata J, Mukai N, Kamatani Y, Momozawa Y, Kubo M, Ninomiya T, Association Between Genetic Risk and Development of Type 2 Diabetes in a General Japanese Population: The Hisayama Study., J Clin Endocrinol Metab , 3213-3222, 104: 3213-3222, 2019, 2019.08.
110. NCD Risk Factor Collaboration (NCD-RisC)(Hata J, Ninomiya T), Rising rural body-mass index is the main driver of the global obesity epidemic in adults., Nature , 260-264, 569: 260-264, 2019, 2019.08.
111. Yamaguchi-Kabata Y, Morihara T, Ohara T, Ninomiya T, Takahashi A, Akatsu H, Hashizume Y, Hayashi N, Shigemizu D, Boroevich KA, Ikeda M, Kubo M, Takeda M, Tsunoda T, Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-β accumulation in Alzheimer's disease., Hum Genet , 137, 521-533, 137: 521-533, 2018, 2019.07.
112. Mukai N, Hata J, Hirakawa Y, Ohara T, Yoshida D, Nakamura U, Kitazono T, Ninomiya T, Trends in the prevalence of type 2 diabetes and prediabetes in a Japanese community, 1988–2012: the Hisayama Study., Diabetol Int , 198-205, 10: 198-205, 2019, 2019.07.
113. Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Ohno-Matsui K, Hata J, Ishibashi T, Ninomiya T, Sonoda KH, Trends in the prevalence of myopia and myopic maculopathy in a Japanese population: the Hisayama Study., Invest Ophthalmol Vis Sci , 2781-2786, 60: 2781-2786, 2019, 2019.07.
114. Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Tokumoto M, Hirakata H, Ooboshi H, Kitazono T, Tsuruya K, Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy., Nephrol Dial Transplant, 33, 963-971, 33: 963-971, 2018, 2019.06.
115. Yoshida D, Ohara T, Hata J, Shibata M, Hirakawa Y, Honda T, Uchida K, Takasugi S, Kitazono T, Kiyohara Y, Ninomiya T, Dairy consumption and risk of functional disability in an elderly Japanese population: the Hisayama Study., Am J Clin Nutr, 109: 1664-1671, 2019, 2019.06.
116. Hamasaki H, Honda H, Suzuki SO, Shijo M, Ohara T, Hatabe Y, Okamoto T, Ninomiya T, Iwaki T, Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: the Hisayama study., 415-423, Alzheimers Dement (Amst) 11: 415-423, 2019, 2019.06.
117. Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, Kiyama M, Yamada M, Ishikawa S, Murakami Y, Miura K, Ueshima H, Okamura T; Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH–JAPAN) Research Group (Ninomiya T, Kiyohara Y), Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study., J Clin Lipidol , 12, 674-684, 12: 674-684, 2018, 2019.05.
118. Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V, Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis., Diabetes Obes Metab, 1237-1250, 21: 1237-1250, 2019, 2019.05.
119. Tomiyama H, Ohkuma T, Ninomiya T, Mastumoto C, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Aboyans V, Yamashina A; Collaborative Group for J-BAVELs, Steno-stiffness approach for cardiovascular disease risk assessment in primary prevention., Hypertension , 73, 508-513, 73: 508-513, 2019, 2019.03.
120. Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaëlsson K, Markus HS; MEGASTROKE project of the International Stroke Genetics Consortium (Ninomiya T), Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study., Neurology , 92, e944-e950, 92: e944-e950, 2019, 2019.03.
121. Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Aboyans V, Yamashina A; collaborative group for the Japan Brachial-Ankle pulse wave VELocity individual participant data meta-analysis of prospective studies to examine the significance of the Ankle-Brachial Index (J-BAVEL-ABI), Ankle-brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population: An individual participant data meta-analysis., Atherosclerosis , 275, 141-148, 275: 141-148, 2018, 2019.02.
122. Yonemoto K, Honda T, Kishimoto H, Yoshida D, Hata J, Mukai N, Shibata M, Hirakawa Y, Ninomiya T, Kumagai S, Longitudinal changes of physical activity and sedentary time in the middle-aged and older Japanese population: the Hisayama Study., J Phys Act Health , 16, 165-171, 16: 165-171, 2019, 2019.02.
123. Emerging Risk Factors Collaboration (Ninomiya T, Doi Y, Kiyohara Y), Cardiovascular risk factors associated with venous thromboembolism., JAMA Cardiol, 4, 163-173, 4: 163-173, 2019, 2019.02.
124. Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T, Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the Hisayama Study., Ann Neurol , 85, 47-58, 85: 47-58, 2019, 2019.01, 認知症のない久山町高齢住民約1,300名を10年間前向きに追跡し、血清sTREM2レベルと認知症発症の関係、および血清sTREM2が認知症発症の予測能に与える影響を検討した。その結果、血清sTREM2値の上昇に伴い、全認知症、アルツハイマー型認知症、および血管性認知症の発症リスクはいずれも有意に上昇することが判明した。さらに、既知の危険因子と血清sTREM2値を組み合わせることにより、将来の認知症発症の予測精度が有意に改善することを明らかにした。.
125. Nakamura M, Ojima T, Nagahata T, Kondo I, Ninomiya T, Yoshita K, Arai Y, Ohkubo T, Murakami K, Nishi N, Murakami Y, Takashima N, Okuda N, Kadota A, Miyagawa N, Kondo K, Okamura T, Ueshima H, Okayama A, Miura K; NIPPON DATA2010 Research Group, Having few remaining teeth is associated with a low nutrient intake and low serum albumin levels in middle-aged and older Japanese individuals: findings from the NIPPON DATA2010., Environ Health Prev Med , 24, 1-9, 24: 1-9, 2019, 2019.01.
126. Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Paré G, O'Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A, Ihara M, Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis., Circulation, 139, 295-298, 139: 295-298, 2019, 2019.01.
127. Tanaka S, Ninomiya T, Hiyamuta H, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Nakano T, Tsuruya K, Kitazono, Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study., Sci Rep, 9, 1043-1050, 9: 1043-1050, 2019, 2019.01.
128. Tanaka A, Hata J, Akamatsu N, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Ohara T, Mizuno T, Tsuji S, Kitazono T, Ninomiya T, Prevalence of adult epilepsy in a general Japanese population: the Hisayama study., Epilepsia Open, 4: 182-186, 2019, 2019.01.
129. MEGASTROKE Consortium (Ninomiya T, Hata J), GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes., Nat Commun , 9, 5141, 9: 5141, 2018, 2018.12.
130. Honda T, Yoshida D, Hata J, Hirakawa Y, Ishida Y, Shibata M, Sakata S, Kitazono T, Ninomiya T, Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: the Hisayama Study., Atherosclerosis, 279, 38-44, 279: 38-44, 2018, 2018.10, 地域住民を対象とした疫学調査(久山町研究)の成績を用いて、心血管病リスク予測モデルを開発した。脳卒中のリスク予測モデルには、年齢、性別、収縮期血圧、糖尿病、喫煙習慣、運動習慣が、虚血性心疾患のリスク予測モデルには、、年齢、性別、収縮期血圧、糖尿病、HDLコレステロール、LDLコレステロール、喫煙習慣が有意な危険因子として選択された。各モデルにおいて、過剰適合は認められず、充分な識別能が確認された。.
131. Ohara T, Honda T, Hata J, Yoshida D, Mukai N, Hirakawa Y, Shibata M, Kishimoto H, Kitazono T, Kanba S, Ninomiya T, Association between daily sleep duration and risk of dementia and mortality in a Japanese community., J Am Geriatr Soc , 66, 1911-1918, 66: 1911-1918, 2018, 2018.10.
132. VARIABLE BRAIN consortium( Ninomiya T, Ohara T, Oishi E), The association between blood pressure variability (BPV) with dementia and cognitive function: a systematic review and meta-analysis protocol., Syst Rev , 7, 163, 7: 163, 2018, 2018.10.
133. Okabayashi Y, Tsuboi N, Amano H, Miyazaki Y, Kawamura T, Ogura M, Narita I, Ninomiya T, Yokoyama H, Yokoo T, Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study., BMJ Open, 8, e024317, 8: e024317, 2018, 2018.10.
134. Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, Suma S, Shibata Y, Shimazaki Y, Hata J, Ninomiya T, Nakanishi Y, Inoue H, Yamashita Y, Periodontal status and lung function decline in the community: the Hisayama Study., Sci Rep, 8, 13354, 8: 13354, 2018, 2018.09.
135. Oshima M, Toyama T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Hara A, Makino H, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan, Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes., PLoS One, 13, e0201535, 13: e0201535, 2018, 2018.08.
136. Fujiwara K, Yasuda M, Hata J, Oshima Y, Hashimoto S, Yoshitomi T, Kiyohara Y, Ishibashi T, Ninomiya T, Sonoda KH, Prevalence and risk factors for polypoidal choroidal vasculopathy in a general Japanese population: the Hisayama Study., Semin Ophthalmol , 33, 6, 813-819, 33(6): 813-819, 2018  , 2018.07.
137. Yubi T, Hata J, Ohara T, Mukai N, Hirakawa Y, Yoshida D, Gotoh S, Hirabayashi N, Furuta Y, Ago T, Kitazono T, Kiyohara Y, Ninomiya T, Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community., Neurology: Clinical Practice , 8, 223-231, 8: 223-231, 2018, 2018.06.
138. Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Tokumoto M, Hirakata H, Ooboshi H, Kitazono T, Tsuruya K, Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy., Nephrol Dial Transplant , 33, 963-971, 33: 963-971, 2018, 2018.06.
139. Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, Kiyama M, Yamada M, Ishikawa S, Murakami Y, Miura K, Ueshima H, Okamura T; Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH–JAPAN) Research Group (Ninomiya T,Kiyohara Y), Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study., J Clin Lipidol , 12, 674-684, 12: 674-684, 2018, 2018.05.
140. MEGASTROKE Consortium( Ninomiya T, Hata J), Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes., 50, 524-537, Nat Genet 50: 524-537, 2018, 2018.04.
141. Takae K, Hata J, Ohara T, Yoshida D, Shibata M, Mukai N, Hirakawa Y, Kishimoto H, Tsuruya K, Kitazono T, Kiyohara Y, Ninomiya T, Albuminuria increases the risks for both Alzheimer disease and vascular dementia in community-dwelling Japanese elderly: the Hisayama Study., J Am Heart Assoc 7: e006693, 2018, 7, e006693, 2018.01.
142. Shijo M, Honda H, Suzuki SO, Hamasaki H, Hokama M, Abolhassani N, Nakabeppu Y, Ninomiya T, Kitazono T, Iwaki T, Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi., Brain Pathol , 28, 58-71, 28: 58-71, 2018, 2018.01.
143. Nagata M, Hata J, Hirakawa Y, Mukai N, Yoshida D, Ohara T, Kishimoto H, Kawano H, Kitazono T, Kiyohara Y, Ninomiya T, The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: the Hisayama Study., J Epidemiol , 27, 578-583, 2017.12.
144. Castillo E, Leon J, Mazzei G, Abolhassani N, Haruyama N, Saito T, Saido T, Hokama M, Iwaki T, Ohara T, Ninomiya T, Kiyohara Y, Sakumi K, LaFerla FM, Nakabeppu Y, Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation., Sci Rep, 7, 17762-17762, Sci Rep 7: 17762, 2017, 2017.12.
145. Hata J, Fukuhara M, Sakata S, Arima H, Hirakawa Y, Yonemoto K, Mukai N, Kitazono T, Kiyohara Y, Ninomiya T, White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study., Hypertens Res , 40, 937-943, 2017.11.
146. Tanaka S, Ninomiya T, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Kitazono T, Tsuruya K, Impact of blood urea nitrogen to creatinine ratio on mortality and morbidity in hemodialysis patients: The Q-Cohort Study., Sci Rep , 7, 14901-14909, 2017.11.
147. Kudo K, Hata J, Matsumoto K, Shundo Y, Fukuyama S, Inoue H, Kitazono T, Kiyohara Y, Ninomiya T, Nakanishi Y, Association of airflow limitation with carotid atherosclerosis in a Japanese community - the Hisayama Study., Circ J , 81, 1846-1853, 2017.11.
148. Sakata S, Hata J, Fukuhara M, Yonemoto K, Mukai N, Yoshida D, Kishimoto H, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T, Morning and evening blood pressures are associated with intima-media thickness in a general population - the Hisayama Study., Circ J , 81, 1647-1653, 2017.10.
149. Ohara T, Ninomiya T, Author response: Trends in dementia prevalence, incidence, and survival rate in a Japanese community., Neurology , 89, 1930-1931, 2017.10.
150. Ohkuma T, Tomiyama H, Ninomiya T, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Yamashina A; Collaborative Group for Japan Brachial-An, Proposed cutoff value of brachial-ankle pulse wave velocity for the management of hypertension., Circ J , 81, 1540-1542, 2017.09.
151. Mukai N, Ohara T, Hata J, Hirakawa Y, Yoshida D, Kishimoto H, Koga M, Nakamura U, Kitazono T, Kiyohara Y, Ninomiya T, Alternative measures of hyperglycemia and risk of alzheimer's disease in the community: the Hisayama Study., J Clin Endocrinol Metab , 102, 8, 3002-3010    , 102:8 3002-3010, 2017    , 2017.08.
152. Oishi E, Ohara T, Sakata S, Fukuhara M, Hata J, Yoshida D, Shibata M, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T, Day-to-day blood pressure variability and risk of dementia in a general Japanese elderly population: the Hisayama Study., Circulation , 136, 516-525, 2017.08.
153. Tamakoshi A, Nakamura K, Ukawa S, Okada E, Hirata M, Nagai A, Matsuda K, Kamatani Y, Muto K, Kiyohara Y, Yamagata Z, Ninomiya T, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group, Erratum to "Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project" [J Epidemiol 27(3S) (2017) S36-S42]., J Epidemiol , 27, 398-399, 2017.08.
154. Usui T, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Kitazono T, Kiyohara Y, Ninomiya T, Serum non-high-density lipoprotein cholesterol and risk of cardiovascular disease in community dwellers with chronic kidney disease: the Hisayama Study., J Atheroscler Thromb , 24, 706-715, 2017.07.
155. Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Yamashina A; Collaborative Group for J-BAVEL, Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual oarticipant data meta-analysis., Hypertension , 69, 1045-1052, 2017.06.
156. Tomiyama H, Shiina K, Matsumoto-Nakano C, Ninomiya T, Komatsu S, Kimura K, Chikamori T, Yamashina A, The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness., J Am Heart Assoc , 6, e005729, 2017.06.
157. Tanaka S, Ninomiya T, Fujisaki K, Yoshida H, Nagata M, Masutani K, Tokumoto M, Mitsuiki K, Hirakata H, Fujimi S, Kiyohara Y, Kitazono T, Tsuruya K; Fukuoka Kidney disease Registry (FKR) Study Collaboration Group, The Fukuoka Kidney disease Registry (FKR) Study: design and methods., Clin Exp Nephrol, 21, 3, 465-473, 2017.06.
158. Takeuchi K, Ohara T, Furuta M, Takeshita T, Shibata Y, Hata J, Yoshida D, Yamashita Y, Ninomiya T, Tooth loss and risk of dementia in the community: the Hisayama Study., J Am Geriatr Soc , 65, e95-e100, 2017.05.
159. Ozawa M, Yoshida D, Hata J, Ohara T, Mukai N, Shibata M, Uchida K, Nagata M, Kitazono T, Kiyohara Y, Ninomiya T, Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama Study., Int J Chron Obstruct Pulmon Dis , 12, 1469-1481, 2017.05.
160. Ohara T, Hata J, Yoshida D, Mukai N, Nagata M, Iwaki T, Kitazono T, Kanba S, Kiyohara Y, Ninomiya T, Trends in dementia prevalence, incidence, and survival rate in a Japanese community., Neurology , 88, 1925-1932, 2017.05.
161. Hata J, Nagai A, Hirata M, Kamatani Y, Tamakoshi A, Yamagata Z, Muto K, Matsuda K, Kubo M, Nakamura Y; Biobank Japan Cooperative Hospital Group., Kiyohara Y, Ninomiya T; Collaborator, Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project., J Epidemiol, 27, 3s, S71-S76, 27:3s S71-S76, 2017.03.
162. Nagai A, Hirata M, Kamatani Y, Muto K, Matsuda K, Kiyohara Y, Ninomiya T, Tamakoshi A, Yamagata Z, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y; BioBank Japan Cooperative Hospital Group., Kubo M, Overview of the BioBank Japan Project: Study design and profile., J Epidemiol, 27, 3s, S2-S8, 27:3s S2-S8, 2017, 2017.03.
163. Okada E, Ukawa S, Nakamura K, Hirata M, Nagai A, Matsuda K, Ninomiya T, Kiyohara Y, Muto K, Kamatani Y, Yamagata Z, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Tamakoshi A, Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project., J Epidemiol, 27, 3s, S29-S35, J Epidemiol 27:3s S29-S35, 2017, 2017.03.
164. Nakamura K, Ukawa S, Okada E, Hirata M, Nagai A, Yamagata Z, Ninomiya T, Muto K, Kiyohara Y, Matsuda K, Kamatani Y, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Tamakoshi A, Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project., J Epidemiol, 27, 3s, S49-S57, 27: 3s S49-S57, 2017, 2017.03.
165. Yokomichi H, Nagai A, Hirata M, Kiyohara Y, Muto K, Ninomiya T, Matsuda K, Kamatani Y, Tamakoshi A, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Yamagata Z, Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort., J Epidemiol, 27, 3s, S98-S106, J Epidemiol 27: S98-S106, 2017, 2017.03.
166. Ukawa S, Okada E, Nakamura K, Hirata M, Nagai A, Matsuda K, Yamagata Z, Kamatani Y, Ninomiya T, Kiyohara Y, Muto K, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Tamakoshi A, Characteristics of patients with liver cancer in the BioBank Japan project., J Epidemiol, 27, 3s, S43-S48, 27:3s S43-S48, 2017, 2017.03.
167. Ukawa S, Nakamura K, Okada E, Hirata M, Nagai A, Yamagata Z, Muto K, Matsuda K, Ninomiya T, Kiyohara Y, Kamatani Y, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Tamakoshi A, Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project., J Epidemiol, 27, S65-S70, 2017.03.
168. Nakamura K, Okada E, Ukawa S, Hirata M, Nagai A, Yamagata Z, Kiyohara Y, Muto K, Kamatani Y, Ninomiya T, Matsuda K, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Tamakoshi A, Characteristics and prognosis of Japanese female breast cancer patients: The BioBank Japan project., J Epidemiol, 27, 3, S58-S64, 27: S58-S64, 2017, 2017.03.
169. Hirakawa Y, Ninomiya T, Kiyohara Y, Murakami Y, Saitoh S, Nakagawa H, Okayama A, Tamakoshi A, Sakata K, Miura K, Ueshima H, Okamura T; Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN), Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: An overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN)., J Epidemiol, 27, 3, 123-129, J Epidemiol 27: 123-129, 2017, 2017.03.
170. Hirata M, Kamatani Y, Nagai A, Kiyohara Y, Ninomiya T, Tamakoshi A, Yamagata Z, Kubo M, Muto K, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y; BioBank Japan Cooperative Hospital Group., Matsuda K, Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases., J Epidemiol, 27, 3s, S9-S21, J Epidemiol 27:3s S9-S21, 2017, 2017.03.
171. Hirata M, Nagai A, Kamatani Y, Ninomiya T, Tamakoshi A, Yamagata Z, Kubo M, Muto K, Kiyohara Y, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y; BioBank Japan Cooperative Hospital Group., Matsuda K, Overview of BioBank Japan follow-up data in 32 diseases., J Epidemiol, 27, 3s, S22-S28, 27: S22-S28, 2017, 2017.03.
172. Yokomichi H, Nagai A, Hirata M, Tamakoshi A, Kiyohara Y, Kamatani Y, Muto K, Ninomiya T, Matsuda K, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Yamagata Z, Statin use and all-cause and cancer mortality: BioBank Japan cohort., J Epidemiol, 27, 3s, S84-S91, 27: S84-S91, 2017, 2017.03.
173. Yokomichi H, Noda H, Nagai A, Hirata M, Tamakoshi A, Kamatani Y, Kiyohara Y, Matsuda K, Muto K, Ninomiya T, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Yamagata Z, Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan., J Epidemiol, 27, 3s, S77-S83, J Epidemiol 27: S77-S83, 2017, 2017.03.
174. Tamakoshi A, Nakamura K, Ukawa S, Okada E, Hirata M, Nagai A, Matsuda K, Kamatani Y, Muto K, Kiyohara Y, Yamagata Z, Ninomiya T, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group, Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project., J Epidemiol, 27, 3s, S36-S42, J Epidemiol 27: S36-S42, 2017, 2017.03.
175. Shimazaki Y, Fu B, Yonemoto K, Akifusa S, Shibata Y, Takeshita T, Ninomiya T, Kiyohara Y, Yamashita Y, Stimulated salivary flow rate and oral health status., J Oral Sci, 59, 1, 55-62, J Oral Sci 59: 55-62, 2017, 2017.03.
176. Hachiya T, Kamatani Y, Takahashi A, Hata J, Furukawa R, Shiwa Y, Yamaji T, Hara M, Tanno K, Ohmomo H, Ono K, Takashima N, Matsuda K, Wakai K, Sawada N, Iwasaki M, Yamagishi K, Ago T, Ninomiya T, Fukushima A, Hozawa A, Minegishi N, Satoh M, Endo R, Sasaki, Genetic predisposition to ischemic stroke: a polygenic risk score., Stroke, 48, 2, 253-258, 2017.02.
177. NCD Risk Factor Collaboration (NCD-RisC) (Ninomiya T), Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants., Lancet, 389, 37-55, Lancet 389: 37-55, 2017, 2017.01.
178. Ikeda F, Shikata K, Hata J, Fukuhara M, Hirakawa Y, Ohara T, Mukai N, Nagata M, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T, Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study., J Epidemiol, 26, 12, 629-636, 2016.12.
179. Hirabayashi N, Hata J, Ohara T, Mukai N, Nagata M, Shibata M, Gotoh S, Furuta Y, Yamashita F, Yoshihara K, Kitazono T, Sudo N, Kiyohara Y, Ninomiya T, Association Between Diabetes and Hippocampal Atrophy in Elderly Japanese: the Hisayama Study., Diabetes Care, 39, 9, 1543-1549, 2016.09.
180. Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiy T, Strippoli GF, Jardine MJ, Interventions for lowering plasma homocysteine levels in kidney transplant recipients., Cochrane Database Syst Rev, 5, CD007910,, 2016.08.
181. Liyanage T, Ninomiya T, Wang A, Neal B, Jun M, Wong MG, Jardine M, Hillis GS, Perkovic V., Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis., PLoS One, 11, 8, 2016.08.
182. Tsukuya G, Samukawa T, Matsumoto K, Fukuyama S, Kumamoto T, Uchida A, Koriyama C, Ninomiya T, Inoue H, Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study., Int J Chron Obstruct Pulmon Dis, 11, 8, 1903-1909, 2016.08.
183. Hata J, Mukai N, Nagata M, Ohara T, Yoshida D, Kishimoto H, Shibata M, Hirakawa Y, Endo M, Ago T, Kitazono T, Oike Y, Kiyohara Y, Ninomiya T, Serum Angiopoietin-Like Protein 2 Is a Novel Risk Factor for Cardiovascular Disease in the Community: the Hisayama Study., Arterioscler Thromb Vasc Biol , 36, 8, 1686-1691, 36:8 1686-1691, 2016, 2016.08.
184. Shibata M, Ninomiya T, Anno K, Kawata H, Iwaki R, Sawamoto R, Kubo C, Kiyohara Y, Sudo N, Hosoi M, Perceived inadequate care and excessive overprotection during childhood are associated with greater risk of sleep disturbance in adulthood: the Hisayama Study., BMC Psychiatry , 16, 215, 16: 215, 2016, 2016.07.
185. Qiu M, Sato S, Zheng D, Wang X, Carcel C, Hirakawa Y, Sandset EC, Delcourt C, Arima H, Wang J, Chalmers J, Anderson CS; INTERACT Investigators, Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies., Stroke, 47, 6, 1479-1485, 2016.06.
186. Hashimoto S, Yasuda M, Ninomiya T, Hata J, Yoshida D, Tahara-Asakuma T, Hirakawa Y, Arakawa S, Fujiwara K, Kiyohara Y, Ishibashi T, Foveal and Macular Thickness in a Japanese Population: the Hisayama Study., Ophthalmic Epidemiol, 23, 202-208, 23: 202-208, 2016, 2016.06.
187. Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H, Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials., Am J Kidney Dis, 2016.05.
188. Honda H, Sasaki K, Hamasaki H, Shijo M, Koyama S, Ohara T, Ninomiya T, Kiyohara Y, Suzuki SO, Iwaki T, Trends in autopsy-verified dementia prevalence over 29 years of the Hisayama study., Neuropathology, 2016.05.
189. Hirakawa Y, Arima H, Webster R, Zoungas S, Li Q, Harrap S, Lisheng L, Hamet P, Mancia G, Poulter N, Neal B, Williams B, Rogers A, Woodward M, Chalmers J, Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes., J Hypertens, 34, 4, 781-787, 2016.04.
190. NCD Risk Factor Collaboration (NCD-RisC) (Hata J, Ninomiya T), Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants., Lancet, 387, 1513-1530, 387: 1513-1530, 2016, 2016.04.
191. Kishimoto H, Ohara T, Hata J, Ninomiya T, Yoshida D, Mukai N, Nagata M, Ikeda F, Fukuhara M, Kumagai S, Kanba S, Kitazono T, Kiyohara Y, The long-term association between physical activity and risk of dementia in the community: the Hisayama Study., Eur J Epidemiol, 2016.03.
192. Lambers Heerspink HJ, Ninomiya T, Persson F, Brenner BM, Brunel P, Chaturvedi N, Desai AS, Haffner SM, Mcmurray JJ, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D, Is a reduction in albuminuria associated with renal and cardiovascular protection? A post-hoc analysis of the ALTITUDE trial., Diabetes Obes Metab, 18, 169-77, 2016.02.
193. Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, Beiser A, Borenstein AR, Crane PK, Haan M, Hassing LB, Hayden KM, Kiyohara Y, Larson EB, Li CY, Ninomiya T, Ohara T, Peters R, Russ TC, Seshadri S, Strand BH, Walker R, Xu W, Huxley RR, Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia., Diabetes Care, 39, 300-307, 2016.02.
194. Takeshita T, Kageyama S, Furuta M, Tsuboi H, Takeuchi K, Shibata Y, Shimazaki Y, Akifusa S, Ninomiya T, Kiyohara Y, Yamashita Y, Bacterial diversity in saliva and oral health-related conditions: the Hisayama Study., Sci Rep, 2016.02.
195. Hamasaki H, Honda H, Okamoto T, Koyama S, Suzuki SO, Ohara T, Ninomiya T, Kiyohara Y, Iwaki T, Recent Increases in Hippocampal Tau Pathology in the Aging Japanese Population: the Hisayama Study., J Alzheimers Dis, 55, 2, 613-624, 2016.02.
196. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis., Lancet, 387, 435-443, 2016.01.
197. Tanaka S, Ninomiya T, Masutani K, Nagata M, Tsuchimoto A, Tsuruya K, Kitazono T, Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy., Clin Exp Nephrol, 19, 1062-1070, 2015.12.
198. Fujiwara K, Yasuda M, Ninomiya T, Hata J, Hashimoto S, Yoshitomi T, Kiyohara Y, Ishibashi T, Insulin Resistance Is a Risk Factor for Increased Intraocular Pressure: The Hisayama Study., Invest Ophthalmol Vis Sci, 56, 7983-7987, 2015.12.
199. Ohkuma T, Hirakawa Y, Nakamura U, Kiyohara Y, Kitazono T, Ninomiya T., Association between eating rate and obesity: a systematic review and meta-analysis., Int J Obes (Lond), 39, 1589-1596, 2015.11.
200. Ohara T, Ninomiya T, Hata J, Ozawa M, Yoshida D, Mukai N, Nagata M, Iwaki T, Kitazono T, Kanba S, Kiyohara Y, Midlife and Late-Life Smoking and Risk of Dementia in the Community: The Hisayama Study., J Am Geriatr Soc, 63, 2332-2339, 2015.11.
201. Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K, The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy., Clin Exp Nephrol, 2015.11.
202. Kondo H, Ninomiya T, Hata J, Hirakawa Y, Yonemoto K, Arima H, Nagata M, Tsuruya K, Kitazono T, Kiyohara Y, Angiotensin I-converting enzyme gene polymorphism enhances the effect of hypercholesterolemia on the risk of coronary heart disease in a general Japanese population: the Hisayama Study., J Atheroscler Thromb, 22, 390-403, 2015.10.
203. Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Fukuhara M, Ikeda F, Ago T, Kitazono T, Kiyohara Y, Hematocrit and the risk of cardiovascular disease in a Japanese community: the Hisayama Study, Atherosclerosis, 242, 199-204, 2015.09.
204. Hirano A, Ohara T, Takahashi A, Aoki M, Fuyuno Y, Ashikawa K, Morihara T, Takeda M, Kamino K, Oshima E, Okahisa Y, Shibata N, Arai H, Akatsu H, Ikeda M, Iwata N, Ninomiya T, Monji A, Kitazono T, Kiyohara Y, Kubo M, Kanba S, A genome-wide association study of late-onset Alzheimer's disease in a Japanese population., Psychiatr Genet, 25, 139-146, 2015.08.
205. NCD Risk Factor Collaboration (Ninomiya T), Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants., Lancet Diabetes Endocrinol, 8, 624-637, 2015.08.
206. Takeuchi K, Furuta M, Takeshita T, Shibata Y, Shimazaki Y, Akifusa S, Ninomiya T, Kiyohara Y, Yamashita Y, Serum antibody to Porphyromonas gingivalis and periodontitis progression: the Hisayama Study., J Clin Periodontol, 42, 719-725, 2015.08.
207. Anno K, Shibata M, Ninomiya T, Iwaki R, Kawata H, Sawamoto R, Kubo C, Kiyohara Y, Sudo N, Hosoi M, Paternal and maternal bonding styles in childhood are associated with the prevalence of chronic pain in a general adult population: the Hisayama Study., BMC Psychiatry, 15, 181-181, 2015.07.
208. Wang AY, Bellomo R, Cass A, Finfer S, Gattas D, Myburgh J, Chadban S, Hirakawa Y, Ninomiya T, Li Q, Lo S, Barzi F, Sukkar L, Jardine M, Gallagher MP; POST-RENAL Study Investigators and the ANZICS Clinical Trials Group:, Health-related quality of life in survivors of acute kidney injury: the Prolonged Outcomes Study of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy study outcomes., Nephrology (Carlton), 20, 492-498, 2015.07.
209. Mukai N, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, Kitazono T, Kiyohara Y, Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study., Cardiovasc Diabetol, 14, 84-84, 2015.06.
210. Liyanage T, Ninomiya T (Double first author), Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V, Worldwide access to treatment for end-stage kidney disease: a systematic review, Lancet, 6736, 61601-61609, 2015.05, 世界199か国のうち、123か国の腎代替療法を受けている患者数のデータを収集し、全世界の腎代替療法をうけている患者数を推計した。その結果、全世界で腎代替療法を受けている患者数(2010年) は、2.62 百万人 と推定された。そのうち、約60%は国民総所得の高い国で行われており、低所得の国ではと治療を受けられずに亡くなっていることが示唆された。さらに、腎代替療法を受ける患者数の将来推計を行った結果、今後アジア地区での患者数が増大することが予測された。.
211. Eriguchi R, Taniguchi M, Ninomiya T, Hirakata H, Fujimi S, Tsuruya K, Kitazono T, Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study., J Nephrol, 28, 217-225, 2015.04.
212. Takeuchi K, Furuta M, Takeshita T, Shibata Y, Shimazaki Y, Akifusa S, Ninomiya T, Kiyohara Y, Yamashita Y., Risk factors for reduced salivary flow rate in a Japanese population: the Hisayama study, Biomed Res Int, 381821, 2015.02.
213. Tsuruya K, Fukuma S, Wakita T, Ninomiya T, Nagata M, Yoshida H, Fujimi S, Kiyohara Y, Kitazono T, Uchida K, Shirota T, Akizawa T, Akiba T, Saito A, Fukuhara S., Dietary patterns and clinical outcomes in hemodialysis patients in Japan: a cohort study., PLoS One , 21, 10(1), e0116677, 2015.01.
214. Tsukuya G, Matsumoto K, Fukuyama S, Crawford B, Nakanishi Y, Ichinose M, Machida K, Samukawa T, Ninomiya T, Kiyohara Y, Inoue H, Hisayama Pulmonary Physiology Study Group., Allergol Int, 64, 49-53, 2015.01.
215. Wang AY, Bellomo R, Ninomiya T, Lo S, Cass A, Jardine M, Gallagher M; RENAL Study Investigators; ANZICS Clinical Trials Group, Angiotensin-converting enzyme inhibitor usage and acute kidney injury: a secondary analysis of RENAL study outcomes, Nephrology (Carlton), 19, 617-622, 2014.10.
216. Kishimoto H, Hata J, Ninomiya T, Nemeth H, Hirakawa Y, Yoshida D, Kumagai S, Kitazono T, Kiyohara Y, Midlife and late-life handgrip strength and risk of cause-specific death in a general Japanese population: the Hisayama Study, J Epidemiol Community Health, 68, 663-668, 2014.07.
217. Ozawa M, Ohara T, Ninomiya T, Hata J, Yoshida D, Mukai N, Nagata M, Uchida K, Shirota T, Kitazono T, Kiyohara Y, Milk and dairy consumption and risk of dementia in an elderly Japanese population: the hisayama study, J Am Geriatr Soc, 62, 1224-1230, 2014.07.
218. Wang AY, Ninomiya T, Al-Kahwa A, Perkovic V, Gallagher MP, Hawley C, Jardine MJ, Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials, Am J Kidney Dis, 63, 968-978, 2014.06.
219. Imamura T, Doi Y, Ninomiya T, Hata J, Nagata M, Ikeda F, Mukai N, Hirakawa Y, Yoshida D, Fukuhara M, Kitazono T, Kiyohara Y, Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study, Atherosclerosis, 233, 343-348, 2014.04.
220. Kojima I, Ninomiya T, Hata J, Fukuhara M, Hirakawa Y, Mukai N, Yoshida D, Kitazono T, Kiyohara Y, A Low Ankle Brachial Index is Associated with an Increased Risk of Cardiovascular Disease: The Hisayama Study, J Atheroscler Thromb, 21, 966-973, 2014.04.
221. Shibata M, Ninomiya T, Jensen MP, Anno K, Yonemoto K, Makino S, Iwaki R, Yamashiro K, Yoshida T, Imada Y, Kubo C, Kiyohara Y, Sudo N, Hosoi M, Alexithymia is associated with greater risk of chronic pain and negative affect and with lower life satisfaction in a general population: the Hisayama Study, PLoS One, 12, e90984, 2014.03.
222. Mukai N, Doi Y, Ninomiya T, Hirakawa Y, Nagata M, Yoshida D, Hata J, Fukuhara M, Nakamura U, Kitazono T, Kiyohara Y, Trends in the prevalence of type 2 diabetes and prediabetes in community-dwelling Japanese subjects: The Hisayama Study, J Diabetes Investig, 5, 162-169, 2014.03.
223. Mukai N, Yasuda M, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, Kitazono T, Kiyohara Y, Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study, Cardiovasc Diabetol, 13, 45, 2014.02.
224. Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Fukuhara M, Ikeda F, Shikata K, Kamouchi M, Kitazono T, Kiyohara Y, Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community, Circ J, 78, 403-409, 2014.01.
225. Izumaru K, Ninomiya T, Nagata M, Usui T, Yoshida D, Yonemoto K, Fukuhara M, Tsuruya K, Kitazono T, Kiyohara Y, Serum 1,25-Dihydroxyvitamin D and the Development of Kidney Dysfunction in a Japanese Community, Circ J 2014, 78, 732-737, 2014.01.
226. Ninomiya T, Nagata M, Hata J, Hirakawa Y, Ozawa M, Yoshida D, Ohara T, Kishimoto H, Mukai N, Fukuhara M, Kitazono T, Kiyohara Y, Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study, Atherosclerosis, 231, 261-267, 2013.12.
227. Masutani K, Ninomiya T, Randhawa P, HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia, Nephrol Dial Transplant, 28, 3119-3126, 2013.11.
228. Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, Hirakata H, Tsuruya K, Kitazono T, Development and validation of a prediction rule using the Oxford classification in IgA nephropathy, Clin J Am Soc Nephrol, 8, 2082-2090, 2013.11.
229. Ikeda F, Doi Y, Ninomiya T, Hirakawa Y, Mukai N, Hata J, Shikata K, Yoshida D, Matsumoto T, Kitazono T, Kiyohara Y, Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study, Cardiovasc Diabetol, 12, 164, 2013.11.
230. Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A, Baigent C, Chalmers J, Li N, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists’ Collaboration, Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials, BMJ, 347, f5680, 2013.10.
231. Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, Fukuhara M, Ikeda F, Shikata K, Yoshida D, Yonemoto K, Kamouchi M, Kitazono T, Kiyohara Y, Secular trends in cardiovascular disease and its risk factors in Japanese: half century data from the Hisayama Study, Circulation, 128, 1198-1205, 2013.09.
232. Sekita A, Arima H, Ninomiya T, Ohara T, Doi Y, Hirakawa Y, Fukuhara M, Hata J, Yonemoto K, Ga Y, Kitazono T, Kanba S, Kiyohara Y, Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study, BMC Public Health, 13, 862, 2013.09.
233. Nakano T, Ninomiya T, Sumiyoshi S, Onimaru M, Fujii H, Itabe H, Nakashima Y, Sueishi K, Tsuruya K, Oda Y, Kitazono T, Kiyohara Y, Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama Study, Kidney Int, 84, 373-380, 2013.08.
234. Toyama T, Furuichi K, Ninomiya T, Shimizu M, Hara A, Iwata Y, Kaneko S, Wada T, The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis, PLoS One, 8, e71810, 2013.08.
235. Nagata M, Ninomiya T, Kiyohara Y, Murakami Y, Irie F, Sairenchi T, Miura K, Okamura T, Ueshima H, Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort stu dies in Japan, Am J Epidemiol, 178, 1-11, 2013.07.
236. Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, Yonemoto K, Mukai N, Nagata M, Ikeda F, Matsumura K, Kitazono T, Kiyohara Y, White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama Study, Stroke, 44, 1512-1517, 2013.06.
237. Nagata M, Ninomiya T, Doi Y, Hata J, Ikeda F, Mukai N, Tsuruya K, Oda Y, Kitazono T, Kiyohara Y, Temporal trends in sudden unexpected death in a general population: the Hisayama Study, Am Heart J , 165, 932-938, 2013.06.
238. Usui T, Ninomiya T, Nagata M, Takahashi O, Doi Y, Hata J, Fukuhara M, Kitazono T, Oike Y, Kiyohara Y, Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population, Circ J, 77, 2311-2317, 2013.06.
239. Shikata K, Ninomiya T, Yonemoto K, Ikeda F, Hata J, Doi Y, Fukuhara M, Matsumoto T, Iida M, Kitazono T, Kiyohara Y, Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study, Scand J Gastroenterol, 47, 669-675, 2012.06.
240. Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y, Hirakawa Y, Matsumura K, Kitazono T, Kiyohara Y, Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study, J Hypertens, 30, 893-900, 2012.05.
241. Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, Fulcher G, de Galan BE, Harrap S, Hamet P, Heller S, Macmahon S, Marre M, Poulter N, Travert F, Patel A, Neal B, Woodward M; for the ADVANCE Collaborative Group, Association of HbA(1c) levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds., Diabetologia, 55, 636-643, 2012.03.
242. Iida M, Ikeda F, Ninomiya T, Yonemoto K, Doi Y, Hata J, Matsumoto T, Iida M, Kiyohara Y, White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study., Am J Epidemiol, 175, 504-510, 2012.03.
243. Mukai N, Doi Y, Ninomiya T, Hata J, Hirakawa Y, Fukuhara M, Iwase M, Kiyohara Y, Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study, Diabet Med, 29, 99-106, 2012.01.
244. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Iwase M, Kiyohara Y, Two risk score models for 2 diabetes in Japan., Diabet Med, 29, 107-114, 2012.01.
245. Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H, Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation, Clin J Am Soc Nephrol, 6, 2806-2813, 2011.12.
246. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y, N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community: The Hisayama Study., Arterioscler Thromb Vasc Biol, 31, 2997-3003, 2011.12.
247. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S, Kiyohara Y, Glucose tolerance status and risk of dementia in the community: The Hisayama Study, Neurology, 77, 1126-1134, 2011.09.
248. Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J, Kanba S, Iwaki T, Kiyohara Y., Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study., Hypertension, 58, 22-28, 2011.07.
249. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT; the Chronic Kidney Disease Prognosis Consortium, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, et al., Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts., Kidney Int, 79, 1341-1352, 2011.06.
250. Ohara T, Ninomiya T, Kubo M, Hirakawa Y, Doi Y, Hata J, Iwaki T, Kanba S, Kiyohara Y., Apolipoprotein Genotype for Prediction of Alzheimer’s Disease in Older Japanese: The Hisayama Study., J Am Geriatr Soc, 59, 1074-1079, 2011.06.
251. Usui T, Ninomiya T, Nagata M, Doi Y, Hata J, Fukuhara M, Kiyohara Y., Albuminuria as a Risk Factor for Peripheral Arterial Disease in a General Population., J Atheroscler Thromb, 18, 705-712, 2011.05.
252. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, Jong PE, Coresh J; The Chronic Kidney Disease Prognosis Consortium, Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, et al., Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts., Kidney Int, (in press), 2011.01.
253. Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, Lambers Heerspink HJ, Perkovic V, Huxley R, Arima H, Patel A, Chalmers J, Woodward M, Macmahon S, Neal B; on behalf of the Blood Pressure Lowering Treatment Trialists? Collaboration., The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials., J Hypertens, 29, 40649, 2011.01.
254. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S; ADVANCE Collaborative Group., Severe hypoglycemia and risks of vascular events and death., N Engl J Med, 363, 1410-1418, 2010.01.
255. Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, Arima H, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y., Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study., Acta Psychiatr Scand, 122, 319-325, 2010.01.
256. Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group., Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial., J Hypertens, 28, 1141-1149, 2010.01.
257. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, Tsuruya K, Iida M, Kiyohara Y, Sueishi K., Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study., Am J Kidney Dis, 55, 21-30, 2010.01.
258. Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, Tsuruya K, Iida M, Kiyohara Y., Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study., Nephrol Dial Transplant, 25, 2557-2564, 2010.01.
259. Jun M, Heerspink HJ, Ninomiya T, Gallagher M, Bellomo R, Myburgh J, Finfer S, Palevsky PM, Kellum JA, Perkovic V, Cass A., Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis., Clin J Am Soc Nephrol, 5, 956-963, 2010.01.
260. Jardine MJ, Ninomiya T, Perkovic V, Cass A, Turnbull F, Gallagher MP, Zoungas S, Lambers Heerspink HJ, Chalmers J, Zanchetti A., Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial., J Am Coll Cardiol, 56, 956-965, 2010.01.
261. Heerspink HJ, Ninomiya T, Perkovic V, Woodward M, Zoungas S, Cass A, Cooper M, Grobbee DE, Mancia G, Mogensen CE, Neal B, Chalmers J; ADVANCE Collaborative Group., Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease., Eur Heart J, 31, 2888-2896, 2010.01.
262. Czernichow S, Ninomiya T, Huxley R, Kengne AP, Batty GD, Grobbee DE, Woodward M, Neal B, Chalmers J., Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial., Hypertension, 55, 1193-1198, 2010.01.
263. de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group., Lowering blood pressure reduces renal events in type 2 diabetes., J Am Soc Nephrol, 20, 883-892, 2009.01.
264. Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, MacMahon S, Marre M, Neal B, Patel A, Woodward M, Chalmers J; ADVANCE Collaborative Group, Cass A, Glasziou P, Harrap S, Lisheng L, Mancia G, Pillai A, Poulter N, Perkovic V, Travert F., Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial., Diabetes Care, 32, 2068-2074, 2009.01.
265. Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, Patel A, Vasheghani-Farahani A, Sadigh G, Perkovic V., Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy., Ann Intern Med, 151, 631-638, 2009.01.
266. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M., Intensive glucose control and macrovascular outcomes in type 2 diabetes., Diabetologia, 52, 2288-2298, 2009.01.
267. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group., Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes., J Am Soc Nephrol, 20, 1813-1821, 2009.01.
268. Ninomiya T, Perkovic V, Verdon C, Barzi F, Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC, Huxley R., Proteinuria and stroke: a meta-analysis of cohort studies., Am J Kidney Dis, 53, 417-425, 2009.01.
269. Ninomiya T, Donnan G, Anderson N, Bladin C, Chambers B, Gordon G, Sharpe N, Chalmers J, Woodward M, Neal B; PROGRESS Collaborative Group., Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)., Stroke, 40, 2111-2115, 2009.01.
270. Heerspink HJ, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine MJ, Gallagher M, Roberts MA, Cass A, Neal B, Perkovic V., Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials., Lancet, 373, 1009-1015, 2009.01.
271. Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GY, Patel A; ADVANCE Collaborative Group., Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study., Eur Heart J, 30, 1128-1135, 2009.01.
272. Doi Y, Ninomiya T, Hata J, Yonemoto K, Tanizaki Y, Arima H, Liu Y, Rahman M, Iida M, Kiyohara Y., Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan., J Epidemiol, 19, 56-62, 2009.01.
273. Doi Y, Ninomiya T, Hata J, Yonemoto K, Arima H, Kubo M, Tanizaki Y, Iwase M, Iida M, Kiyohara Y., Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study., Stroke, 40, 1187-1194, 2009.01.
274. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, Perkovic V, Li N, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration., Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials., Eur Heart J, 29, 2669-2680, 2008.01.
275. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration., Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials., BMJ, 336, 1121-1123, 2008.01.
276. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, Jardine M, Gallagher M, Turnbull F, Chalmers J, Craig J, Huxley R., The relationship between proteinuria and coronary risk: a systematic review and meta-analysis., PLoS Med, 5, e207, 2008.01.
277. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F; ADVANCE Collaborative Group., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes., N Engl J Med, 358, 2560-2572, 2008.01.
278. Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H; Japan Arteriosclerosis Longitudinal Study Group., Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study., Circulation, 118, 2694-2701, 2008.01.
279. Katafuchi R, Ninomiya T, Mizumasa T, Ikeda K, Kumagai H, Nagata M, Hirakata H., The improvement of renal survival with steroid pulse therapy in IgA nephropathy., Nephrol Dial Transplant, 23, 3915-3920, 2008.01.
280. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B; ADVANCE Collaborative Group., Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial., Lancet, 370, 829-840, 2007.01.
281. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, Sueishi K, Tsuneyoshi M, Iida M, Kiyohara Y., Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study., J Am Soc Nephrol, 18, 2135-2142, 2007.01.
282. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y., Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study., Stroke, 38, 2063-2069, 2007.01.
283. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y., A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction., Nat Genet, 39, 212-217, 2007.01.
284. Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M., Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study., Am J Kidney Dis, 48, 383-391, 2006.01.
285. Kubo M, Kiyohara Y, Ninomiya T, Tanizaki Y, Yonemoto K, Doi Y, Hata J, Shikata K, Iida M., Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population., Neurology, 66, 1539-1544, 2006.01.
286. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M., Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study., Kidney Int, 10.1111/j.1523-1755.2005.00397.x, 68, 1, 228-236, 2005.01.
287. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, Nakamura H, Hata J, Oishi Y, Kato I, Hirakata H, Iida M., Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study., Am J Kidney Dis, 10.1053/j.ajkd.2004.05.024, 44, 3, 437-445, 2004.01.
288. Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M., Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways., Am J Physiol Renal Physiol, 10.1152/ajprenal.00311.2002, 285, 2, F208-F218, 2003.01.
289. Ninomiya T, Kanai H, Hirakawa M, Arimura Y, Masutani K, Kashiwagi M, Nakamura S, Koga Y, Fukuda K, Hirakata H., Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis superimposed on biopsy-proven diabetic nephrosclerosis., Am J Kidney Dis, 10.1053/ajkd.2002.29925, 39, 1, E4, 2002.01.
290. Ninomiya T, Takimoto H, Matsuzaki G, Hamano S, Yoshida H, Yoshikai Y, Kimura G, Nomoto K., Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma., Immunology, 10.1046/j.1365-2567.2000.00938.x, 99, 2, 187-194, 2000.01.
291. Nishie A, Yoshimitsu K, Honda H, Kaneko K, Kuroiwa T, Fukuya T, Irie H, Ninomiya T, Yoshimitsu T, Hirakata H, Okuda S, Masuda K., Treatment of hepatic encephalopathy by retrograde transcaval coil embolization of an ileal vein-to-right gonadal vein portosystemic shunt., Cardiovasc Intervent Radiol, 10.1007/s002709900142, 20, 3, 222-224, 1997.01.